Earli mission is to make cancer a benign experience. Rather than rely on biomarkers that cancer may - or often may not - naturally provide, Earli's technology *forces* cancer cells to make a synthetic, non-human biomarker using gene therapy approaches. It's called a Synthetic Biopsy. It can then localize the cancer in a PET scanner. Earli has been funded by Andreessen Horowitz's Bio Fund, Khosla, Perceptive Advisors, Casdin Capital, Sands Capital, Marc Benioff, Menlo Ventures, ZhenFund. Earli is based in the West Coast’s prime biotech hub in South San Francisco.
View Top Employees from Earli Inc.Website | https://earli.com/ |
Revenue | $201000 |
Funding | $40 million |
Employees | 41 (41 on RocketReach) |
Founded | 2018 |
Address | 1400 Bridge Pkwy Suite 201, Redwood City, California 94065, US |
Phone | (650) 250-4152 |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Decision/Risk Analysis, Business Services, Biotechnology |
SIC | SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Earli Inc. employee's phone or email?
The Earli Inc. annual revenue was $201000 in 2024.
Maggie Louie is the Vice President, Research of Earli Inc..
41 people are employed at Earli Inc..
Earli Inc. is based in Redwood City, California.
The NAICS codes for Earli Inc. are [3254, 325, 32].
The SIC codes for Earli Inc. are [80, 283, 28].